PBS additions for cancer and epilepsy Tens of thousands of patients each year are set to benefit from several first-time additions, including Zyamis and Tecentriq SC.
Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Diabetes medication restrictions incoming More red tape is on the way after the PBAC recommended GPs gain additional approval before starting patients on Qtern 5/10.
Government reveals disability royal commission response Healthcare changes are on the way after 130 recommendations were accepted in principle, but the future of several key asks remains unclear.
Can a virtual ED reduce diabetes hospitalisations? A new initiative is hoped to ease ED loads and improve access to treatment, but there are concerns it may also fragment general practice care.
Cystic fibrosis medication expanded on PBS Doctors can soon prescribe subsidised Trikafta to children earlier, in a ‘lifechanging’ move set to save families $250,000 each year.
New PSR boss seeks to reassure GPs As he embarks on a three-year term in the top job, Antonio Di Dio wants to dispel myths that the watchdog is a ‘scary, hidden monster’.
Calls for expansion of multidisciplinary pain management The latest pain report shines a light on the need for multidisciplinary programs to be scaled up, in a bid to increase access and reduce stigma.
Contracts – the basics every doctor should know SPONSORED: From payment arrangements to medical records, there are several key aspects GPs need to consider.
‘Enough talking’: Government called upon to help GPs treat diabetes Health leaders must act upon recent expert advice pleading for urgent improvement to patients’ access to quality diabetes care, says the RACGP.